propagermanium has been researched along with Obesity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akamizu, T; Arai, H; Ariyasu, H; Kanamori, H; Kita, T; Murayama, T; Ono, K; Sugimoto, M; Tamura, Y; Ueda, Y; Yokode, M | 1 |
| Akamizu, T; Arai, H; Ariyasu, H; Kita, T; Minami, M; Murayama, T; Nishikaze, Y; Sugimoto, M; Tamura, Y; Yokode, M | 1 |
2 other study(ies) available for propagermanium and Obesity
| Article | Year |
|---|---|
Inhibition of CCR2 ameliorates insulin resistance and hepatic steatosis in db/db mice.
Topics: Adipose Tissue; Adiposity; Animals; Cell Size; Fatty Liver; Germanium; Insulin Resistance; Liver; Macrophages; Male; Metabolic Syndrome; Mice; Mice, Mutant Strains; Mice, Obese; Obesity; Organometallic Compounds; Propionates; Receptors, CCR2; Triglycerides; Weight Gain | 2008 |
C-C chemokine receptor 2 inhibitor improves diet-induced development of insulin resistance and hepatic steatosis in mice.
Topics: Adipose Tissue; Animal Feed; Animals; Body Weight; Fatty Liver; Germanium; Inflammation; Insulin Resistance; Lipids; Male; Mice; Mice, Inbred C57BL; Obesity; Organometallic Compounds; Propionates; Receptors, CCR2; Tumor Necrosis Factor-alpha | 2010 |